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ABSTRACT 
 
We sought to examine the relationship globally between UV dose exposure and current eczema 
prevalences. 
 
ISAAC Phase Three provided data on eczema prevalence for 13-14 year-olds in 214 centres in 87 
countries and for 6-7 year-olds in 132 centres in 57 countries. Linear and non-linear associations 
between (natural log transformed) eczema prevalence and the mean, maximum, minimum, 
standard deviation and range of monthly UV dose exposures were assessed using linear mixed-
effects regression models.  
 
For the 13-14 year olds, the country-level eczema prevalence was positively and linearly 
associated with country-level monthly mean (prevalence ratio: 1.31, 95% confidence interval: 
[1.05, 1.63] per kJ/m2) and minimum (1.25 [1.06, 1.47] per kJ/m2) UV dose exposure. Linear and 
non-linear associations were also observed for other metrics of UV. Results were similar in trend, 
but non-significant, for the fewer centres with 6-7 year-olds (e.g. 1.24 [0.96, 1.59] per kJ/m2 for 
country-level monthly mean UV). No consistent within-country associations were observed (e.g. 
1.05 [0.89, 1.23] and 0.92 [0.71, 1.18] per kJ/m2 for center-level monthly mean UV, for the 13-14 
and 6-7 year-olds, respectively). 
 
These ecological results support a role for UV exposure in explaining some of the variation in 
global childhood eczema prevalence.  
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INTRODUCTION 
Childhood atopic dermatitis, also known as eczema, is a highly prevalent condition strongly 
associated with genetic risk factors, such as mutations in the filaggrin gene (Irvine et al. 2011, 
Weidinger and Novak 2016). However, differences in global prevalence (Williams et al. 2008), 
associations with family size and results from migrant studies (Williams 1995) all suggest 
environmental factors are also likely to play a role.  
 
Although the evidence of the effectiveness of short-term ultraviolet radiation treatment on 
eczema (in adults) is increasing (Garritsen et al. 2014), little is known about the effects of long-
term exposure. Climatic and ultraviolet radiation (UV) long-term exposures have been associated 
with eczema prevalence and severity of symptoms in studies in North America and Europe 
(Kathuria and Silverberg 2016, Krämer et al. 2005, Sargen et al. 2014, Silverberg et al. 2013, 
Suárez-Varela et al. 2008, Vocks et al. 2001). Overall, these studies suggest that climatic factors, 
such as temperature and humidity, as well as UV exposure, may influence eczema prevalence and 
symptoms, although the direction and consistency of the effects vary across studies. Indeed, 
Langan and Irvine (2013) recently reviewed the existing conflicting evidence and called for 
additional large studies to clarify the associations and elucidate potential mechanisms. In 
particular, no study has yet included data from developing countries, where eczema prevalences 
are increasing (Williams et al. 2008) and where UV exposures can be high. A better 
understanding of the existing relationships between the environment and eczema development 
and prevalence could lead to opportunities for early intervention and (possibly) climate-specific 
treatment regimes (Langan and Irvine et al 2013). 
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A previous study using data from the International Study of Asthma and Allergies in Childhood 
(ISAAC) Phase One reported that childhood and adolescent eczema prevalence were positively 
correlated with latitude and negatively correlated with annual outdoor temperature in Western 
Europe. One explanation provided was a potential indirect effect due to changes in behaviour and 
sun exposure, which would also be correlated with temperature and latitude (Weiland et al. 2004). 
The current study extends this work by using the substantially larger ISAAC Phase Three data set 
(Odhiambo et al. 2009) to examine associations between metrics of UV dose exposures and the 
prevalence of current eczema among children and adolescents in a global context. 
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RESULTS 
For the 214 centres with 13-14 year-olds, the median centre-level eczema prevalence was 5.73 
(range: 0.17-24.6) and varied by climate type (analysis of variance, P = 0.06; Table 1). The 
median centre-level prevalence for the 132 centres with 6-7 year-olds was 6.99 (range: 0.95-
22.5). Centre-level prevalences between the age groups were highly correlated for the 129 centres 
that had information for both age groups (Spearman correlation = 0.76). Centre-specific sample 
sizes, eczema prevalences and monthly mean UV dose exposures are reported in Tables S1 and 
S2 for the 13-14 year-olds and 6-7 year-olds, respectively. 
 
Among the many correlations observed between the modeled variables (presented in Table 2 for 
the centres with 13-14 year-olds), centre-level eczema prevalence was positively correlated with 
country-level gross national income (GNI) and centre-level relative humidity, and negatively 
correlated with the centre-level standard deviation and range of monthly UV levels. The different 
measures of UV exposures were inter-correlated. These correlations were very similar for the 
centres with 6-7 year-olds (Table S3).  
 
Between-country associations (comparing country-level information) are reported in Table 3 
(both age groups) and the shape of these associations are depicted in Figure 1 and Figure S1 for 
the 13-14 and 6-7 year-olds, respectively. For the centres with 13-14 year-olds, country-level 
monthly mean, maximum and minimum UV levels were positively associated with country-level 
current eczema prevalence (prevalence ratio: 1.31 [95% confidence interval: 1.05, 1.63], 1.25 
[1.00, 1.57] and 1.25 [1.06, 1.47], respectively). When quadratic terms (exposure2) were 
introduced into the models for maximum, standard deviation and range of monthly UV, as this 
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represents a better model fit to the data, the quadratic terms were all statistically significant, 
suggesting the existence of non-linear relationships. When replicated in the centres with 6-7 year-
olds, the effect estimates were similar in trend, but were attenuated and none were statistically 
significant. The results from the models containing linear terms only are presented as prevalence 
ratios in Table S4 (this type of presentation is inappropriate for models containing linear and 
quadratic terms). 
 
Two significant negative linear within-country associations (comparing centres within countries) 
were observed for centres with 13-14 year-olds  but these did not replicate in the centres with 6-7 
year-olds (Table 3). 
 
Stratification by whether or not eczema first occurred before or at/after the age of two years 
suggest that the between-country associations (comparing country-level information) could be 
driven by the later phenotype (Table 4). This analysis could only be conducted among centres 
with 6-7 year-olds as this information was not collected from the 13-14 year-olds. 
 
Although statistical significance was occasionally lost, the effect estimates were highly consistent 
when the outcome was restricted to eczema symptoms which kept the participant awake one or 
more nights per week (severe eczema, Table S5), despite a substantial reduction in centre-level 
prevalences (median prevalence was 7.0% for current eczema and 0.8% when restricted to severe 
symptoms).   
 
The removal of centres with the lowest and highest centre-level eczema prevalences or centre-
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
level UV exposures (up to 10% of the sample removed) did not alter the between-country 
associations (comparing country-level information). Removal of the two countries with the 
lowest and highest country-level UV exposure metrics (4 countries in total out of 87) also yielded 
fairly consistent results, although the between-country associations for monthly mean and 
minimum UV were attenuated and no longer significant.  When 10% of the sample was removed 
based on country-level UV exposure extremes, the between-country effect estimates were similar 
in trend but nearly all were no longer significant.  
 
Stratification by climate type suggested that the between-country associations (comparing 
country-level information) were most apparent among areas with climates classified as warm 
temperate and fully humid, although there may be an insufficient number of centres in the other 
climate groups to detect associations (Table 5).   
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DISCUSSION 
Main Findings 
In this worldwide ecological analysis, several between-country associations between metrics of 
UV exposure and current eczema prevalence were observed among centres with 13-14 year-
oldsOur results suggest a positive linear association between country-level eczema prevalence 
with country-level mean and minimum monthly UV dose levels (which were highly correlated, rs 
= 0.98) and non-linear relationships between the country-level maximum, standard deviation and 
range of monthly UV dose levels (the latter two of which were highly correlated, rs = 0.99). When 
replicated in the centres with 6-7 year-olds, these associations were similar in trend but were not 
statistically significant, most likely because of the fewer number of centres in this age-group.  
 
Comparison with other Studies 
Previous studies on this topic point to a complex relationship. The most recent efforts include a 
longitudinal study in Germany in which some participants reported that their eczema symptoms 
were worse in the summer, yet others reported worse symptoms in the winter (Krämer et al. 
2005). This effect was thought to be at least partly driven by environmental allergen exposure and 
sensitization. Two recent studies in the United States of America published a year apart came to 
rather different conclusions. A large-scale ecological study reported reduced eczema prevalence 
in areas with (among other things) high relative humidity, high UV index and high mean 
temperature (Silverberg et al. 2013), whereas a prospective cohort study reported that warm, 
humid and high sun exposure climates were associated with poorly controlled eczema (Sargen et 
al. 2014).  Furthermore, a recent large population-based ecological study in the United States of 
America demonstrated the complexity that likely exists between coexisting climatic factors and 
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pollutants. For example, this study reported that areas classified as hot, sunny, and with high 
levels of ozone and particulate matter with an aerodynamic diameter of 10 µm or less had lower 
eczema prevalence (Kathuria and Silverberg 2016). The results of the current analysis add to this 
complexity by suggesting the existence of both linear and non-linear associations (on a global 
scale) with different metrics of UV dose exposure. The possibility that extremes of UV exposure 
in either direction might increase the risk of eczema is not implausible and could help reconciliate 
the current seemingly conflicting data from different regions and study designs. Our finding that 
associations were strongest in countries classified as warm temperate and fully humid is also 
interesting, but should be interpreted cautiously due to the smaller number of countries in the 
other climate groups. 
 
Possible Mechanisms  
Several biological mechanisms by which UV exposure may affect eczema symptoms have been 
proposed, including UV-epidermal interactions (Schwarz and Schwarz 2011), UV-induced DNA 
methylation and gene-environment interactions. Indirect or interactive effects with other climatic 
factor, such as humidity and temperature, are also probable (Langan and Irvine 2013). It is 
unknown how these interactions may have resulted in the non-linear relationships observed for 
certain metrics of UV dose exposure. Sensitivity analyses in which up to 10% of the sample were 
removed did not largely change the non-linear associations, suggesting that these relationships 
are not driven by a small subset of outlying centres. Although all models were adjusted for a 
variety of important factors, these adjustments are unlikely to address all potential relevant 
factors and interactions.  
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We were unable to investigate whether differences in the distribution of important genetic risk 
factors may be confounding our associations as it was not feasible to collect genetic data. It is 
known that the prevalence and profiles of mutations in the FLG gene vary geographically and it 
has been suggested that certain mutations may correlate with UV exposure (Cascella et al. 2015). 
Further, areas of the skin more exposed to climatic and physical stressors have been shown to be 
affected more often in FLG mutation carriers, suggesting that filaggrin-deficient individuals may 
have a reduced ability to adapt to environmental exposures (Carson et al. 2012). Interestingly, 
genetic risk factors appear to have the strongest influence on early-life eczema (by the first year 
(Bønnelykke et al. 2010)), whereas the associations in our study were most consistent for eczema 
with first onset at/after two years of age. One could thus speculate that any effect of UV exposure 
would be more apparent (or easier to detect) after the influence of genetic risk factors has taken 
place. The results of our age-stratified analyses should however be interpreted with caution given 
that this analysis could only be conducted in centres with 6-7 year-olds.  
 
Strengths and Limitations of Study 
The between-country associations are based on the entire data set and thereby take advantage of 
the large number and exposure contrasts of the participating countries. However, these 
associations are more likely than the within-country associations to be influenced by unmeasured 
factors that differ by country, and issues related to the translation of questionnaires (Ellwood et 
al. 2009). We thus cannot confirm that the between-country associations are not driven by 
residual confounding. We found no consistent within-country associations, possibly because of a 
smaller exposure range and sample size as only countries with more than one centre could 
contribute. 
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Our definition of eczema was identical to the standardized and validated definition used to assess 
worldwide differences and changes in eczema prevalences in the successive phases of ISAAC 
(Williams et al. 2008), and has been shown to provide adequate prevalence estimates at the 
population level (Flohr et al. 2009). It nevertheless remains possible that there may be variation 
in the way the questionnaires were completed or administered, although all study centres 
followed the same protocol. The fact that similar patterns with UV exposures were observed for 
eczema symptoms classified as severe supports the existence of a harmonized approach as severe 
symptoms are less likely to be deferentially reported than mild symptoms. Previous studies have 
reported that eczema flares during particular times of the year and in response to weather effects 
(Krämer et al. 2005; Langan et al. 2009), which could be associated with UV exposure levels. We 
could not examine season-specific associations as the questionnaire asked for eczema prevalence 
over a 12 month period. This gap should be addressed in future work. 
 
The size and coverage of ISAAC, which includes regions rarely or never studied in this context, 
makes this study unique in its ability to investigate global associations between ecologic metrics 
of UV dose exposures and current eczema prevalence However, there remain areas of the world 
which are poorly covered in this analysis, such as countries with colder climates. It should also be 
noted that the participating centres were not randomly selected. Thus it is unknown whether the 
results may be generalizable worldwide. Given these limitations, we recommend focusing on the 
trends of the associations presented (Figure 1), which may indicate new directions for research, 
and not on the exact values of the effect estimates reported. 
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The UV exposure data was selected to overlap with the beginning of the health data collection 
period for ISAAC Phase Three. Any temporal changes in UV exposures that occurred between 
the time of birth of the participants and the time the health data were collected are expected to be 
minimal compared to the differences in UV exposures between countries and centres. For the rest 
of the adjustment covariates, we attempted to use data from the same period although not all data 
sets overlap. Common to all ecological studies, we had no information on potentially relevant 
individual-level factors, such as race or skin type, and were thus unable to explore effect 
modification by behavioral factors that could influence an individual's exposure to UV, such as 
time spent outdoors and wearing sun-protective clothing. Nonetheless, the collection of data from 
both 13-14 year-olds and 6-7 year-olds allowed nearly all analyses to be replicated in an 
independent population. We focused on associations that were statistically significant in the larger 
group of centres (the 13-14 year olds) and that replicated at least in trend in the fewer centres 
with 6-7 year-olds. This was the case for all the between-country associations but no within-
country associations.  
 
In conclusion, we provide further support for a role of environmental factors on eczema. Several 
between-country associations between metrics of UV dose exposure and current eczema 
prevalence were observed, with some indication that non-linear associations may exist on a 
global scale. Given the ecological design of this study and the possibility of residual 
confounding, these results should be interpreted with caution until replicated using individual 
exposure data in a prospective study design.  
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METHODS 
 
Study Population 
The rationale and methods for ISAAC Phase Three have been published (Ellwood et al. 2005). 
The current analysis includes information on 214 centres in 87 countries for the 13-14 year-olds 
and 132 centres in 57 countries for the 6-7 year-olds for which the required health and 
environmental data were available (flow chart in Figure S2). Ethical approval from local ethics 
committees or boards were obtained for all collaborating centres. Parental completion of the 
questionnaire for the 6-7 year-olds implied consent. For the older age group, passive consent for 
the teenager to complete their own questionnaire at school was mostly used. In each age-group, 
the person completing the questionnaire was informed about the nature and purpose of the study 
before commencing the questionnaire.  
 
Health Outcomes 
Using standardized self-completed (for adolescents 13-14 years-old) or parent-completed (for 
children 6-7 years-old) ISAAC questionnaires, individuals were asked to indicate if they (or their 
child) had an itchy rash at any time in the last 12 months and whether this itchy rash had affected 
any of the following places: the folds of the elbows, behind the knees, in front of the ankles, 
under the buttocks, or around the neck, ears or eyes? A positive answer to both questions was 
used to define current eczema and centre prevalences of this outcome were calculated as the 
mean prevalence of each center (Odhiambo et al. 2009). Subsequent questions asked about the 
age of first onset of the itchy rash symptoms and how often these symptoms kept the participant 
awake at night. Using this information, centre-level prevalences of eczema with first onset before 
versus at/after age two years, as well as severe eczema (kept the participant awake one or more 
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nights per week) were calculated. The exact wording of all questions on eczema are provided in 
the Supplementary Material. 
 
Methods Relating to Environmental Assessments 
Monthly data on UV radiation dose in the erythema range (280-400nm, believed to be important 
for the effects on human skin (McKinlay and Diffey 1987)) were obtained from the Tropospheric 
Emission Monitoring Internet Service for the year 2001, at a resolution of 0.5o x 0.5o (European 
Space Agency). UV dose data were used, instead of UV index data, as the former is a measure of 
the total amount of UV radiation absorbed by the human skin during the day (kJ/m2) after 
considering cloud cover.   
 
Population density data for 2000 (at a spatial resolution of 2.5 arc minutes) were obtained from 
the Socioeconomic Data and Applications centre (Socioeconomic Data and Applications Center 
2004). Data on GNI  per capita in 2001 were obtained from the World Bank (Atlas Method 2003; 
(World Bank 2012)). For the seven countries for which this information was missing, GNI data 
were imputed using information from the Central Intelligence Agency World Fact Book (2003) 
(Central Intelligence Agency 2007). 
 
Data on monthly mean daily temperature and precipitation averaged for 1991 - 2000 for 0.5o x 
0.5o grids were obtained from the Intergovernmental Panel on Climate Change Data Distribution 
centre (Mitchell 2004; Mitchell and Jones 2005). These data were used to classify centres into 
five climate types according to the Köppen climate classification system ( (Kottek et al. 2006)). 
Monthly mean relative humidity data, averaged for 1961-1990 and available at a 10' resolution, 
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was also obtained (New et al. 2002).  
 
The assignment of environmental variables to the centres has been described (Anderson et al. 
2012; Fuertes et al. 2014). For each center, coordinates for the study population were assigned to 
a 0.1o x 0.1o square and compared with the eight surrounding 0.1o x 0.1o squares. The square with 
the highest population density was considered the centre grid and used for mapping. UV dose and 
climate data were mapped to this single coordinate. For population density, the mean values of 
the centre grid and eight surrounding grids (each sized 0.07o x 0.07o) were used. For UV dose, 
climate and population density variables, which were available at the centre-level, country-level 
means were calculated (Begg and Parides 2003), which may not reflect the true mean of a 
country.  
 
Analytic Strategy 
Correlations between centre-level variables were assessed using Spearman correlation 
coefficients. Eczema prevalences were (natural) log-transformed before modeling. Linear 
regression mixed models were used to assess associations between the mean, maximum, 
minimum, standard deviation and range of monthly UV dose exposures and current eczema 
prevalence (lme4 package (Bates et al. 2014) in the statistical program R, version 3.3.0 (R Core 
Team 2012), unstructured covariance structure). Effect plots (from the effects package (Fox et al. 
2016)) were created to graphically display the terms of the regression models. Given this study’s 
ecological design, the unit of analysis was “country” for the between-country associations in 
which country-level information was compared, and “center” for the within-country associations 
in which center-level information within countries was compared. 
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Initially, models containing only a linear term for each UV exposure variable were calculated and 
are presented. High-order relationships were subsequently tested by including quadratic terms 
(e.g. UV2). Evidence of non-linearity was observed for the maximum, standard deviation and 
range of monthly UV dose exposures for the between-country associations in the 13-14 year-old 
age group. Thus, for these exposures only, models containing linear and quadratic terms (which 
better fit the data) are also presented.  
 
Models were adjusted for potential confounding factors including GNI per capita, population 
density, climate type and monthly mean temperature and relative humidity. All models included 
country as a random intercept and fixed effects for both the centre- and country-level 
representation of each variable, except for GNI per capita, which was available only at the 
country-level.  
 
The regression coefficients (betas) and their corresponding 95% confidence intervals, calculated 
as 1.96*(standard error) assuming a normal distribution, are presented for the linear and quadratic 
terms per 1-unit increase in country-level exposure for the between-country associations and per 
1-unit increase in centre-level exposure for the within-country associations. For models 
containing only linear UV terms, the beta estimates can be interpreted as prevalence ratios after 
natural exponentiation, per increase in UV exposure. For the models containing linear and 
quadratic terms, it is not possible to summarize the results using a single number that reflects 
additive or relative changes (Barrera-Gómez and Basagaña 2015). Thus, in all Tables, the beta 
estimates are not back-transformed from the (natural) logarithmic scale so that the models 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
17 
containing only linear UV terms can be compared to those containing linear and quadratic UV 
terms.   
 
Sensitivity analyses 
To assess the impact of outliers, separate analyses were conducted in which 1) the five centres 
with the lowest and highest centre-level eczema prevalence (~5% of sample) were removed, 2) 
the five centres with the lowest and highest centre-level UV exposure metric were removed (~5% 
sample), and 3) the two countries with the lowest and highest country-level UV exposure metric 
were removed (~5% of the 87 country-level UV exposures). These analyses were replicated with 
~10% removed instead. 
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Table 1: Distribution of current centre-level eczema symptom prevalence and centre-level UV dose exposure variables overall, and by 
climate type, for centres with 13-14 year-olds (N=214) 
 
 Overall 
(N=214) 
Snow/polar 
(N=12) 
Arid 
(N=24) 
Equatorial 
(N=61) 
Warm temperate 
with dry winter 
(N=20) 
Warm temperate 
fully humid 
(N=97) 
 Median IQR Median IQR Median IQR Median IQR Median IQR Median IQR 
Eczema symptoms 5.7 5.5 3.8 4.9 4.6 4.7 6.9 6.5 4.9 4.6 7.0 6.3 
UV monthly mean 3.3 2.3 2.0 0.8 3.1 1.2 4.5 0.3 1.7 0.6 2.6 1.7 
UV monthly maximum 5.2 1.4 4.0 1.1 5.4 1.0 5.5 0.3 3.5 0.8 4.9 1.7 
UV monthly minimum 1.1 2.6 0.4 0.4 0.9 1.0 3.4 0.7 0.2 0.2 0.7 1.3 
UV monthly SD 1.3 0.6 1.3 0.3 1.5 0.4 0.7 0.3 1.3 0.2 1.4 0.4 
UV monthly range 3.3 1.5 3.6 0.8 4.2 1.0 2.2 0.8 3.3 0.5 3.7 1.2 
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Table 2: Spearman correlations between modeled centre-level variables for the centres with 13- to 14-year olds (N=214) 
 
Variable Period Median 
(IQR) 
Eczema 
sympto
ms 
GNI per 
capita 
Populati
on 
density 
Temper
ature 
Relative 
humidit
y 
Mean Max Min SD Range 
Eczema symptoms 2000-2003 5.7 (5.5) 1 0.18** -0.06 0.04 0.33*** 0.10 0.06 0.12 -0.17* -0.17* 
GNI per capita per 1000 2001 3.3 (10.6)  1 -0.14* -0.39*** 0.36*** -0.48*** -0.44*** -0.48*** 0.14* 0.13 
Population density per 1000 2000 0.9 (2.4)   1 0.27*** -0.02 0.24** 0.15* 0.27*** -0.23*** -0.22** 
Monthly mean temperature (oC) 1991-2000 18.0 (12.7)    1 -0.02 0.78*** 0.55*** 0.84*** -0.46*** -0.45*** 
Monthly mean relative humidity (%) 1961-1990 73.9 (12.7)      -0.08 -0.23*** -0.03 -0.42*** -0.43*** 
UV monthly mean 2001 3.3 (2.3)      1 0.84*** 0.98*** -0.46*** -0.44*** 
UV monthly maximum 2001 5.2 (1.4)       1 0.79*** -0.01 0.01 
UV monthly minimum 2001 1.1 (2.6)        1 -0.52*** -0.51*** 
UV monthly standard deviation 2001 1.3 (0.6)         1 0.99*** 
UV monthly range 2001 3.3 (1.5)          1 
 
*<0.05; **<0.01; ***<0.001 
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Table 3: Between- and within-country associations for current eczema symptom prevalence and 
UV exposures for the centres with 13-14 year olds and 6-7 year olds. Beta estimates (not back-
transformed from the natural logarithmic scale) and their corresponding 95% confidence intervals 
are presented1  
 
UV exposure  
 
13-14 yr olds 6-7 yr olds 
Linear term Quadratic term Linear term Quadratic term 
 Between-country associations (comparing country-level information) 
 N = 214 centres in 87 countries N = 132 centres in 57 countries 
Mean  0.27 [0.05, 0.49] - 0.21 [-0.04, 0.47] - 
Max2  0.22 [0.00, 0.45] - 0.22 [-0.02, 0.46] - 
 
0.31  [0.08, 0.53] 0.20 [0.05, 0.34] 0.23 [-0.02, 0.48] 0.11 [-0.04, 0.27] 
Min2 0.22   [0.06, 0.39] - 0.14 [-0.07, 0.34] - 
SD2  -0.34  [-0.78, 0.09] - -0.02 [-0.63, 0.59] - 
 
-0.23  [-0.66, 0.20] 1.15 [0.28, 2.02] 0.00 [-0.62, 0.62] 0.21 [-0.75, 1.18] 
Range2  -0.13  [-0.30, 0.05] - 0.02 [-0.21, 0.26] - 
 
-0.10  [-0.27, 0.06] 0.19 [0.06, 0.33] 0.02 [-0.22, 0.25] 0.07 [-0.09, 0.22] 
 Within-country associations (comparing centres within countries) 
 N = 161 centres in 34 countries N = 96 centres in 21 countries 
Mean  0.04 [-0.12, 0.20] - -0.08 [-0.34, 0.17] - 
Max -0.13 [-0.31, 0.05] - -0.08 [-0.35, 0.19] - 
Min 0.13 [-0.01, 0.28] - -0.07 [-0.27, 0.12] - 
SD -0.74 [-1.16, -0.32] - 0.19 [-0.32, 0.70] - 
Range -0.31 [-0.47, -0.14] - 0.03 [-0.17, 0.24] - 
 
1Adjusted for centre mean exposure of interest (for between-country associations) or country mean exposure of 
interest (for within-country associations), as well as the centre and country mean population density, mean monthly 
temperature and mean monthly relative humidity, as well as country gross national per capita income and climate 
type. Estimates from the models containing only linear terms can be interpreted as prevalence ratios after natural 
exponentiation. 
 
2 Results from two models are presented: one including only a linear term for the UV exposure and one including a 
linear and quadratic term for the UV exposure. The significant positive quadratic terms observed for the maximum, 
standard deviation and range of monthly UV measurements among the 13-14 year-olds suggest the existence of a 
non-linear (convex) association with eczema prevalence. 
 
Bold: p-value < 0.05 
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Table 4: Between- and within-country associations for current eczema symptom prevalence and 
UV exposures for the centres with 6-7 year olds, stratified by whether eczema onset was before 
or after age two years. Beta estimates (not back-transformed from the natural logarithmic scale) 
and their corresponding 95% confidence intervals are presented1  
 
UV exposure  Eczema onset before age two years Eczema onset at/after age two years 
 Linear term Quadratic term Linear term Quadratic term 
 Between-country associations (comparing country-level information) 
Mean  0.05 [-0.31, 0.41] - 0.31 [0.05, 0.57] - 
Max2 0.12 [-0.22, 0.47] - 0.28 [0.02, 0.53] - 
 
0.11 [-0.24, 0.46] 0.03 [-0.20, 0.25] 0.28 [0.02, 0.54] 0.12 [-0.04, 0.28] 
Min  -0.01 [-0.30, 0.28] - 0.20 [-0.03, 0.42] - 
SD2  0.26 [-0.59, 1.10] - -0.04 [-0.69, 0.62] - 
 
0.23 [-0.61, 1.08] -0.87 [-2.18, 0.43] -0.03 [-0.69, 0.62] 0.62 [-0.37, 1.61] 
Range2  0.13 [-0.20, 0.46] - 0.00 [-0.25, 0.26] - 
 
0.14 [-0.18, 0.47] -0.11 [-0.32, 0.10] -0.02 [-0.27, 0.23] 0.12 [-0.03, 0.28] 
 Within-country associations (comparing centres within countries) 
Mean  0.08 [-0.27, 0.43] - -0.24 [-0.58, 0.11] - 
Max 0.14 [-0.24, 0.51] - -0.20 [-0.57, 0.17] - 
Min 0.04 [-0.24, 0.32] - -0.21 [-0.49, 0.06] - 
SD 0.12 [-0.60, 0.85] - 0.43 [-0.29, 1.15] - 
Range 0.04 [-0.26, 0.34] - 0.11 [-0.19, 0.41] - 
 
1Adjusted for centre mean exposure of interest (for between-country associations) or country mean exposure of 
interest (for within-country associations), as well as the centre and country mean population density, mean monthly 
temperature and mean monthly relative humidity, as well as country gross national per capita income and climate 
type. Estimates from the models containing only linear terms can be interpreted as prevalence ratios after natural 
exponentiation. 
 
2 Results from two models are presented: one including only a linear term for the UV exposure and one including a 
linear and quadratic term for the UV exposure. 
 
 
Bold: p-value < 0.05 
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Table 5: Between-country associations (comparing country-level information) for current eczema symptom prevalence and UV exposures 
for the centres with 13-14 year-olds, stratified by climate type. Beta estimates (not back-transformed from the natural logarithmic scale) and 
their corresponding 95% confidence intervals are presented1  
 
UV 
exposure  
Arid 
(N=24 centres in 18 countries) 
Equatorial 
(N=61 centres in 31 countries) 
Warm temperate with dry winter 
(N=20 centres in 13 countries) 
Warm temperate fully humid 
(N=97 centres in 139 countries) 
Linear term Quadratic term Linear term Quadratic term Linear term Quadratic term Linear term Quadratic term 
Mean  0.12  
[-0.54, 0.79] 
- -0.11  
[-0.88, 0.67] 
- -0.54  
[-2.92, 1.85] 
- 0.45  
[0.21, 0.69] 
- 
Max2  0.67  
[0.04, 1.30] 
- 0.05  
[-1.05, 1.15] 
- -0.72  
[-1.87, 0.43] 
- 0.51  
[0.22, 0.79] 
- 
 
0.77  
[-0.39, 1.94] 
0.03  
[-1.43, 1.49] 
-2.86  
[-6.68, 0.96] 
2.23  
[-0.57, 5.03] 
-1.94  
[-4.93, 1.05] 
-0.60  
[-2.02, 0.83] 
0.52  
[0.26, 0.79] 
0.22  
[0.05, 0.38] 
Min  -0.07  
[-0.57, 0.42] 
- 0.04  
[-0.36, 0.44] 
- -0.17  
[-6.15, 5.80] 
- 0.29 
[0.10, 0.47] 
- 
SD2  0.63 
 [-0.71 1.96] 
- -0.04  
[-1.03, 0.94] 
- -3.29  
[-8.11, 1.54] 
- -0.37  
[-0.99, 0.26] 
- 
 
0.21 
 [-1.53 1.95] 
1.48  
[-2.12, 5.08] 
0.83  
[-1.03, 2.68] 
1.47  
[-1.19, 4.14] 
-0.40  
[-8.73, 7.92] 
-7.36  
[-23.92, 9.21] 
-0.37  
[-0.93, 0.19] 
2.40  
[0.99, 3.82] 
Range2 0.30 
 [-0.20, 0.79] 
- -0.01  
[-0.43, 0.40] 
- -1.02  
[-2.32, 0.28] 
- -0.13  
[-0.37, 0.12] 
- 
 
0.12 
 [-0.55, 0.78] 
0.27  
[-0.34, 0.87] 
0.22  
[-0.52, 0.97] 
0.16  
[-0.25, 0.56] 
-0.48  
[-2.82, 1.86] 
-0.83  
[-3.07, 1.42] 
-0.19  
[-0.41, 0.02] 
0.40  
[0.18, 0.62] 
 
1Adjusted for centre mean exposure of interest, centre and country mean population density, mean monthly temperature and mean monthly relative humidity, as well as 
country gross national per capita income. Results for snow/polar climates not presented due to an insufficient sample size (12 centres in 8 countries). Estimates from the 
models containing only linear terms can be interpreted as prevalence ratios after natural exponentiation. 
 
2 Results from two models are presented: one including only a linear term for the UV exposure and one including a linear and quadratic term for the UV exposure. The 
significant positive quadratic terms observed for the maximum, standard deviation and range of monthly UV measurements suggest the existence of a non-linear 
(convex) association with eczema prevalence. 
 
Bold: p-value < 0.05
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FIGURE LEGENDS 
 
Figure 1: Effect plots for the between-country associations (comparing country-level 
information) for current eczema symptom prevalence and UV exposures for the centres 
with 13-14 year-olds. The linear effects are presented in the left column and the quadratic effects 
are presented in the right column. The corresponding 95% confidence intervals are shown in grey.  
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